22nd Century Group (XXII) Reports Third Quarter 2023 Financial Results
BUFFALO, N.Y., Nov. 06, 2023 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and wellness with reduced nicotine tobacco, hemp/cannabis and hops, to…
- Third quarter 2023 net revenue of $17.8 million
- Expanded VLN® availability to more than 4,550 stores in 19 states
- Proposed FDA menthol ban regulation now undergoing review at …